Literature DB >> 19222744

Regulatory T cells and viral liver disease.

Nadia Alatrakchi1, Margaret Koziel.   

Abstract

Important questions remain on the role of T cells in progression of hepatitis virus-mediated liver pathogenesis: are T cells 'Good or Bad'? How could one maintain a beneficial balance, in which regulatory T-cell (Treg) populations might play an important role? Treg are a heterogeneous population of cells, including the classical CD4+CD25+ subset expressing the transcription factor Foxp3, CD4 T cells secreting IL-10 (Tr1) or TGF-beta (Th3), but also some CD8 T cells, double negative T cells and gammadelta T cells. The role of Treg in viral hepatitis, particularly HBV and HCV, seems to range from suppressing T-cell responses directed against hepatitis viruses to down-regulating the immune responses causing the liver damage. Questions also remain unresolved on which Treg populations are important and how to establish a beneficial balance, mostly due to the difficulties in studying the heterogeneous Treg populations but also due to the problem accessing liver, the principal target of hepatitis viruses. Here, we will review progress to date on understanding Treg populations in regard to viral hepatitis.

Entities:  

Mesh:

Year:  2009        PMID: 19222744     DOI: 10.1111/j.1365-2893.2009.01081.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  32 in total

1.  Efficacy of telbivudine in the treatment of chronic hepatitis b and liver cirrhosis and its effect on immunological responses.

Authors:  Nan Meng; Xiao Gao; Wei Yan; Mi Wang; Ping Liu; Xiao-Dan Lu; Shu-Juan Zhang; Ya-Qi Lu; Wang-Xian Tang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

2.  The phenotype and activation status of regulatory T cells during Friend retrovirus infection.

Authors:  Jara J Joedicke; Kirsten K Dietze; Gennadiy Zelinskyy; Ulf Dittmer
Journal:  Virol Sin       Date:  2014-01-20       Impact factor: 4.327

3.  Elevated frequency and function of regulatory T cells in patients with active chronic hepatitis C.

Authors:  Kuo-Chih Tseng; Yun-Che Ho; Yu-Hsi Hsieh; Ning-Sheng Lai; Zhi-Hong Wen; Chin Li; Shu-Fen Wu
Journal:  J Gastroenterol       Date:  2012-02-28       Impact factor: 7.527

4.  Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis.

Authors:  Carlo Selmi; Angela Ceribelli; John M Vierling
Journal:  Semin Immunopathol       Date:  2012-12-19       Impact factor: 9.623

5.  Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C.

Authors:  K Yanagisawa; S Yue; H J van der Vliet; R Wang; N Alatrakchi; L Golden-Mason; D Schuppan; M J Koziel; H R Rosen; M A Exley
Journal:  J Viral Hepat       Date:  2013-03-11       Impact factor: 3.728

6.  Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis.

Authors:  Shaoyong Li; Lianne E M Vriend; Imad A Nasser; Yury Popov; Nezam H Afdhal; Margaret J Koziel; Detlef Schuppan; Mark A Exley; Nadia Alatrakchi
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

7.  Amphiregulin promotes the immunosuppressive activity of intrahepatic CD4+ regulatory T cells to impair CD8+ T-cell immunity against hepatitis B virus infection.

Authors:  Kai Dai; Ling Huang; Jing Chen; Lihua Yang; Zuojiong Gong
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

8.  Kinetics of peripheral hepatitis B virus-specific CD8+ T cells in patients with onset of viral reactivation.

Authors:  Jun Aoki; Yuka Kowazaki; Takahiro Ohtsuki; Rumiko Okamoto; Kazuteru Ohashi; Seishu Hayashi; Hisashi Sakamaki; Michinori Kohara; Kiminori Kimura
Journal:  J Gastroenterol       Date:  2012-09-26       Impact factor: 7.527

9.  Immune reconstitution inflammatory syndrome: incidence and implications for mortality.

Authors:  Richard M Novak; James T Richardson; Kate Buchacz; Joan S Chmiel; Marcus D Durham; Frank J Palella; Andrea Wendrow; Kathy Wood; Benjamin Young; John T Brooks
Journal:  AIDS       Date:  2012-03-27       Impact factor: 4.177

Review 10.  Th17 cells and their associated cytokines in liver diseases.

Authors:  Fouad Lafdil; Andrew M Miller; Sung Hwan Ki; Bin Gao
Journal:  Cell Mol Immunol       Date:  2010-03-22       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.